Rss Feed

Subscribe to Rss Feed feed
Latest Medical Research News and Research
Updated: 24 min 8 sec ago

Bioceramic implant can stimulate skull bone regeneration

Mon, 10/19/2020 - 19:10
A bioceramic implant has proved to stimulate regeneration of natural skull bone, so that even large cranial defects can be repaired in a way that has not been possible before. The research, led from the University of Gothenburg, is now presented in the scientific journal PNAS.

KNAUER subsidiary 'Das Labor. GmbH' produces SARS-CoV-2 antibody rapid tests in Africa

Mon, 10/19/2020 - 14:26
‘KNAUER Wissenschaftliche Geräte GmbH’ and its new subsidiary 'Das Labor. GmbH' produce reliable Corona antibody tests in Sub-Saharan Africa.

CBD could reduce lung damage caused by COVID-19

Mon, 10/19/2020 - 11:34
One way CBD appears to reduce the "cytokine storm" that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face of this storm.

RIT researcher receives NSF Convergence Accelerator project

Mon, 10/19/2020 - 11:24
A Rochester Institute of Technology researcher is part of a team that has been awarded a National Science Foundation grant to use artificial intelligence to better understand the role of facial expressions in signed and spoken languages.

Microbiology expert examines antiviral activities of Respiratory Detox Shot

Mon, 10/19/2020 - 11:14
Yuntao Wu, Professor, Molecular and Microbiology, School of Systems Biology, is performing experiments to examine the antiviral activities of Respiratory Detox Shot (RDS).

Even healthy people have "autoreactive" T cells linked to type 1 diabetes, shows study

Mon, 10/19/2020 - 11:11
Your pancreas is studded with cell clusters called islets. In most people, special beta cells live snug in the islets, happily making the insulin that the body uses to regulate blood sugar.

Elevated birth weight is linked with atrial fibrillation later in life, shows study

Mon, 10/19/2020 - 10:46
Elevated birth weight is linked with developing atrial fibrillation later in life, according to research presented at the 31st Great Wall International Congress of Cardiology (GW-ICC).

Patients with congenital heart defects have lower risk of severe COVID-19 symptoms

Mon, 10/19/2020 - 10:35
Adults and children born with heart defects had a lower-than-expected risk of developing moderate or severe COVID-19 symptoms, finds a study of more than 7,000 patients from the congenital heart disease center at Columbia University Vagelos College of Physicians and Surgeons.

New device rapidly transfers delicate tissue or electronic sheets to patients

Mon, 10/19/2020 - 10:29
Thin tissue grafts and flexible electronics have a host of applications for wound healing, regenerative medicine and biosensing.

Researchers study link between psychological responses and risk communication during COVID-19

Mon, 10/19/2020 - 10:21
The mental effects of pandemics on people can arise not only from the burden of preventive measures, the fear of contracting and cure but also coping with the exponential deaths.

Scientists lay out a novel rationale for COVID-19 drug design

Mon, 10/19/2020 - 10:16
American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design - blocking a molecular "scissor" that the virus uses for virus production and to disable human proteins crucial to the immune response.

Dolutegravir is a first-line treatment for people newly diagnosed with HIV

Mon, 10/19/2020 - 10:03
A new study by UBC researchers is set to change international treatment recommendations for people who are newly diagnosed with HIV--an update that could affect nearly two million people per year worldwide.

Engineers visualize how speaking spreads a virus

Mon, 10/19/2020 - 09:59
A team of researchers and engineers at Princeton University has provided a visualization of how speaking produces and expels saliva droplets into the air. The smallest droplets can be inhaled by people, which is the primary mode of transmission of infections such as COVID-19.

Study of patterns of social contacts early on in COVID-19 pandemic

Mon, 10/19/2020 - 09:34
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has compelled people worldwide to quarantine. To mitigate the transmission of SARS-CoV-2, countries and workplaces have been under varying stages of lockdown since the detection of the infection in December 2019 in Wuhan, China.

Concerti algorithm identifies intra-patient heteroplasmies in SARS-CoV-2 patients

Mon, 10/19/2020 - 08:11
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that emerged in Wuhan, China, in late 2019 has caused the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has affected more than 39.8 million lives globally and claimed over 1.11 million deaths to date.

Sinopharm's candidate SARS-CoV-2 vaccine BBIBP-CorV shows promise in clinical trials

Mon, 10/19/2020 - 07:43
Researchers in China have conducted a phase 1/2 trial demonstrating the safety, tolerability, and immunogenicity of a candidate vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

Future waves of COVID-19 will likely lead to further school closures

Mon, 10/19/2020 - 07:21
Researchers in the UK have warned that given how future waves of coronavirus disease 2019 (COVID-19) seem to be inevitable, it is likely that schools will be put under further pressure to close.

Comparative analysis reveals common vulnerabilities across coronaviruses

Mon, 10/19/2020 - 06:41
Three lethal human respiratory syndromes associated with coronavirus (CoV) infections have emerged in the past two decades. They are severe acute respiratory syndrome (SARS) in 2002, Middle East respiratory syndrome (MERS) in 2012, and coronavirus disease 2019 (COVID-19) in 2019.

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

Mon, 10/19/2020 - 06:21
A large-scale randomized trial has recently been conducted by the World Health Organization (WHO) to evaluate the efficacy of four repurposed antiviral medicines, including Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon, currently used to treat hospitalized coronavirus disease 2019 (COVID-19) patients.

Return to college classes tied to a 9 percent increase in COVID-19 cases, study finds

Mon, 10/19/2020 - 05:49
Since a vast majority of colleges and universities in the country are bringing students back for in-person instruction amid the COVID-19 pandemic, the researchers from the University of Georgia wanted to determine the effect of this return to campus on the viral case growth in countries with a significant college student population, compared to non-college countries.

Pages